{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:08:17Z","timestamp":1772183297391,"version":"3.50.1"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P51OD011106"],"award-info":[{"award-number":["P51OD011106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24OD019803"],"award-info":[{"award-number":["R24OD019803"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31HL136047"],"award-info":[{"award-number":["F31HL136047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10286-018-00584-7","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T17:17:56Z","timestamp":1546449476000},"page":"397-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Autonomic dysfunction in Parkinson disease and animal models"],"prefix":"10.1007","volume":"29","author":[{"given":"Jeanette M.","family":"Metzger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-6641","authenticated-orcid":false,"given":"Marina E.","family":"Emborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"issue":"2","key":"584_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J (2002) An essay on the shaking palsy 1817. J Neuropsychiatry Clin Neurosci 14(2):223\u2013236. \n                    https:\/\/doi.org\/10.1176\/jnp.14.2.223\n                    \n                  \n                           (discussion 222)","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"584_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13760-016-0739-6","volume":"117","author":"S Tomic","year":"2017","unstructured":"Tomic S, Rajkovaca I, Pekic V, Salha T, Misevic S (2017) Impact of autonomic dysfunctions on the quality of life in Parkinson\u2019s disease patients. Acta Neurol Belg 117(1):207\u2013211. \n                    https:\/\/doi.org\/10.1007\/s13760-016-0739-6","journal-title":"Acta Neurol Belg"},{"key":"584_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27316","author":"P Fazio","year":"2018","unstructured":"Fazio P, Svenningsson P, Cselenyi Z, Halldin C, Farde L, Varrone A (2018) Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease. Mov Disord. \n                    https:\/\/doi.org\/10.1002\/mds.27316","journal-title":"Mov Disord"},{"issue":"1","key":"584_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28(1):24\u201330. \n                    https:\/\/doi.org\/10.1002\/mds.25032","journal-title":"Mov Disord"},{"issue":"1","key":"584_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autneu.2010.03.018","volume":"165","author":"S Nilsson","year":"2011","unstructured":"Nilsson S (2011) Comparative anatomy of the autonomic nervous system. Autono Neurosci 165(1):3\u20139. \n                    https:\/\/doi.org\/10.1016\/j.autneu.2010.03.018","journal-title":"Autono Neurosci"},{"issue":"5","key":"584_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","volume":"133","author":"DS Goldstein","year":"2000","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133(5):338\u2013347","journal-title":"Ann Intern Med"},{"issue":"5","key":"584_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/mds.25431","volume":"28","author":"JA Palma","year":"2013","unstructured":"Palma JA, Carmona-Abellan MM, Barriobero N, Trevino-Peinado C, Garcia-Lopez M, Fernandez-Jarne E, Luquin MR (2013) Is cardiac function impaired in premotor Parkinson\u2019s disease? A retrospective cohort study. Mov Disord 28(5):591\u2013596. \n                    https:\/\/doi.org\/10.1002\/mds.25431","journal-title":"Mov Disord"},{"key":"584_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autneu.2017.04.002","volume":"205","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS (2017) Autonomic and electrocardiographic findings in Parkinson\u2019s disease. Auton Neurosci 205:93\u201398. \n                    https:\/\/doi.org\/10.1016\/j.autneu.2017.04.002","journal-title":"Auton Neurosci"},{"issue":"3","key":"584_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","volume":"46","author":"S Jain","year":"2012","unstructured":"Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46(3):572\u2013580. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.10.025","journal-title":"Neurobiol Dis"},{"issue":"5","key":"584_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.22457","volume":"24","author":"M Matinolli","year":"2009","unstructured":"Matinolli M, Korpelainen JT, Korpelainen R, Sotaniemi KA, Myllyla VV (2009) Orthostatic hypotension, balance and falls in Parkinson\u2019s disease. Mov Disord 24(5):745\u2013751. \n                    https:\/\/doi.org\/10.1002\/mds.22457","journal-title":"Mov Disord"},{"issue":"6","key":"584_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, Consortium APsD (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with lewy body disorders. Acta Neuropathol 119(6):689\u2013702. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"issue":"4","key":"584_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/ars.2014.5859","volume":"21","author":"JG Greene","year":"2014","unstructured":"Greene JG (2014) Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson\u2019s disease. Antioxid Redox Signal 21(4):649\u2013667. \n                    https:\/\/doi.org\/10.1089\/ars.2014.5859","journal-title":"Antioxid Redox Signal"},{"issue":"Pt 3","key":"584_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awu369","volume":"138","author":"T Gjerloff","year":"2015","unstructured":"Gjerloff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, Danielsen EH, Terkelsen AJ, Hansen J, Pavese N, Brooks DJ, Borghammer P (2015) Imaging acetylcholinesterase density in peripheral organs in Parkinson\u2019s disease with 11C-donepezil PET. Brain 138(Pt 3):653\u2013663. \n                    https:\/\/doi.org\/10.1093\/brain\/awu369","journal-title":"Brain"},{"issue":"12","key":"584_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. \n                    https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"4","key":"584_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara K, Imamura T, Shinya T (2010) Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson\u2019s disease. Parkinsonism Relat Disord 16(4):252\u2013255. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.12.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"584_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 76(2):249\u2013251. \n                    https:\/\/doi.org\/10.1136\/jnnp.2004.037028","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"584_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ana.10236","volume":"52","author":"ST Li","year":"2002","unstructured":"Li ST, Dendi R, Holmes C, Goldstein DS (2002) Progressive loss of cardiac sympathetic innervation in Parkinson\u2019s disease. Ann Neurol 52(2):220\u2013223. \n                    https:\/\/doi.org\/10.1002\/ana.10236","journal-title":"Ann Neurol"},{"issue":"8","key":"584_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/mds.10461","volume":"18","author":"F Courbon","year":"2003","unstructured":"Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, Rascol O, Senard JM (2003) Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease. Mov Disord 18(8):890\u2013897. \n                    https:\/\/doi.org\/10.1002\/mds.10461","journal-title":"Mov Disord"},{"issue":"1","key":"584_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1148\/radiol.12112723","volume":"265","author":"KK Wong","year":"2012","unstructured":"Wong KK, Raffel DM, Koeppe RA, Frey KA, Bohnen NI, Gilman S (2012) Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. Radiology 265(1):240\u2013247. \n                    https:\/\/doi.org\/10.1148\/radiol.12112723","journal-title":"Radiology"},{"issue":"2","key":"584_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2967\/jnumed.116.176891","volume":"58","author":"KK Wong","year":"2017","unstructured":"Wong KK, Raffel DM, Bohnen NI, Altinok G, Gilman S, Frey KA (2017) 2-Year natural decline of cardiac sympathetic innervation in idiopathic parkinson disease studied with 11C-hydroxyephedrine PET. J Nuclear Med 58(2):326\u2013331. \n                    https:\/\/doi.org\/10.2967\/jnumed.116.176891","journal-title":"J Nuclear Med"},{"issue":"Pt 3","key":"584_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain 131(Pt 3):642\u2013650. \n                    https:\/\/doi.org\/10.1093\/brain\/awm302","journal-title":"Brain"},{"issue":"6","key":"584_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental lewy body diseases. Neurology 52(6):1269\u20131271","journal-title":"Neurology"},{"issue":"3","key":"584_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s004010050705","volume":"94","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke\u2019s column in Parkinson\u2019s disease. Acta Neuropathol 94(3):287\u2013289","journal-title":"Acta Neuropathol"},{"issue":"6","key":"584_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","volume":"24","author":"M Gesi","year":"2000","unstructured":"Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F (2000) The role of the locus coeruleus in the development of Parkinson\u2019s disease. Neurosci Biobehav Rev 24(6):655\u2013668","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"584_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410330405","volume":"33","author":"WP Gai","year":"1993","unstructured":"Gai WP, Geffen LB, Denoroy L, Blessing WW (1993) Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson\u2019s disease. Ann Neurol 33(4):357\u2013367. \n                    https:\/\/doi.org\/10.1002\/ana.410330405","journal-title":"Ann Neurol"},{"issue":"8","key":"584_CR26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58(8):1247\u20131255","journal-title":"Neurology"},{"issue":"2","key":"584_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jemt.1070290212","volume":"29","author":"SL Stoddard","year":"1994","unstructured":"Stoddard SL, Merkel GJ, Cook JA, Zinsmeister AR, Carmichael SW (1994) Adrenal medulla and Parkinson\u2019s disease. Microsc Res Tech 29(2):151\u2013154. \n                    https:\/\/doi.org\/10.1002\/jemt.1070290212","journal-title":"Microsc Res Tech"},{"issue":"Suppl 2","key":"584_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 38(Suppl 2):2\u20137","journal-title":"Eur Neurol"},{"issue":"3","key":"584_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1440-1827.2005.01800.x","volume":"55","author":"M Sugie","year":"2005","unstructured":"Sugie M, Goto J, Kawamura M, Ota H (2005) Increased norepinephrine-associated adrenomedullary inclusions in Parkinson\u2019s disease. Pathol Int 55(3):130\u2013136. \n                    https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01800.x","journal-title":"Pathol Int"},{"key":"584_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.05.025","author":"T Umehara","year":"2018","unstructured":"Umehara T, Oka H, Nakahara A, Matsuno H, Toyoda C (2018) High norepinephrinergic orthostatic hypotension in early Parkinson\u2019s disease. Parkinsonism Relat Disord. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.025","journal-title":"Parkinsonism Relat Disord"},{"key":"584_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-0348-8491-4_16","volume-title":"Temperature regulation: recent physiological and pharmacological advances","author":"JA Boulant","year":"1994","unstructured":"Boulant JA (1994) Neurophysiology of thermoregulation: role of hypothalamic neuronal networks. In: Milton AS (ed) Temperature regulation: recent physiological and pharmacological advances. Birkh\u00e4user Basel, Base, pp 93\u2013101. \n                    https:\/\/doi.org\/10.1007\/978-3-0348-8491-4_16"},{"issue":"12","key":"584_CR32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/mds.10586","volume":"18","author":"L Swinn","year":"2003","unstructured":"Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N (2003) Sweating dysfunction in Parkinson\u2019s disease. Mov Disord 18(12):1459\u20131463. \n                    https:\/\/doi.org\/10.1002\/mds.10586","journal-title":"Mov Disord"},{"issue":"6","key":"584_CR33","first-page":"26","volume":"59","author":"JM Beitz","year":"2013","unstructured":"Beitz JM (2013) Skin and wound issues in patients with Parkinson\u2019s disease: an overview of common disorders. Ostomy Wound Manag 59(6):26\u201336","journal-title":"Ostomy Wound Manag"},{"key":"584_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/bs.irn.2017.04.003","volume":"134","author":"WH Jost","year":"2017","unstructured":"Jost WH (2017) Autonomic dysfunction in Parkinson\u2019s disease: cardiovascular symptoms, thermoregulation, and urogenital symptoms. Int Rev Neurobiol 134:771\u2013785. \n                    https:\/\/doi.org\/10.1016\/bs.irn.2017.04.003","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"584_CR35","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/mds.21006","volume":"21","author":"P Schestatsky","year":"2006","unstructured":"Schestatsky P, Valls-Sole J, Ehlers JA, Rieder CR, Gomes I (2006) Hyperhidrosis in Parkinson\u2019s disease. Mov Disord 21(10):1744\u20131748. \n                    https:\/\/doi.org\/10.1002\/mds.21006","journal-title":"Mov Disord"},{"issue":"7","key":"584_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.parkreldis.2007.12.004","volume":"14","author":"K Shindo","year":"2008","unstructured":"Shindo K, Iida H, Watanabe H, Ohta E, Nagasaka T, Shiozawa Z (2008) Sympathetic sudomotor and vasoconstrictive neural function in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 14(7):548\u2013552. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2007.12.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"584_CR37","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00702-005-0431-0","volume":"113","author":"R Dabby","year":"2006","unstructured":"Dabby R, Djaldetti R, Shahmurov M, Treves TA, Gabai B, Melamed E, Sadeh M, Avinoach I (2006) Skin biopsy for assessment of autonomic denervation in Parkinson\u2019s disease. J Neural Trans 113(9):1169\u20131176. \n                    https:\/\/doi.org\/10.1007\/s00702-005-0431-0","journal-title":"J Neural Trans"},{"issue":"18","key":"584_CR38","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R (2013) alpha-Synuclein in cutaneous autonomic nerves. Neurology 81(18):1604\u20131610. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9f449","journal-title":"Neurology"},{"issue":"5","key":"584_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/wnl.0000000000002919","volume":"87","author":"CH Gibbons","year":"2016","unstructured":"Gibbons CH, Garcia J, Wang N, Shih LC, Freeman R (2016) The diagnostic discrimination of cutaneous alpha-synuclein deposition in Parkinson disease. Neurology 87(5):505\u2013512. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000002919","journal-title":"Neurology"},{"issue":"1","key":"584_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler K, Ebert S, Uceyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C (2014) Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology. Acta Neuropathol 128(1):99\u2013109. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1284-0","journal-title":"Acta Neuropathol"},{"key":"584_CR41","doi-asserted-by":"publisher","first-page":"6064974","DOI":"10.1155\/2017\/6064974","volume":"2017","author":"T Siepmann","year":"2017","unstructured":"Siepmann T, Penzlin AI, Illigens BM, Reichmann H (2017) Should skin biopsies be performed in patients suspected of having Parkinson\u2019s disease? Parkinsons Dis 2017:6064974. \n                    https:\/\/doi.org\/10.1155\/2017\/6064974","journal-title":"Parkinsons Dis"},{"issue":"1","key":"584_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","volume":"214","author":"M Politis","year":"2008","unstructured":"Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson\u2019s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214(1):112\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2008.07.021","journal-title":"Exp Neurol"},{"issue":"3","key":"584_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02337479","volume":"8","author":"R Sandyk","year":"1987","unstructured":"Sandyk R, Iacono RP, Bamford CR (1987) The hypothalamus in Parkinson disease. Ital J Neurol Sci 8(3):227\u2013234","journal-title":"Ital J Neurol Sci"},{"key":"584_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","volume":"35","author":"C McDonald","year":"2017","unstructured":"McDonald C, Winge K, Burn DJ (2017) Lower urinary tract symptoms in Parkinson\u2019s disease: prevalence, aetiology and management. Parkinsonism Relat Disord 35:8\u201316. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"584_CR45","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","volume":"82","author":"T Uchiyama","year":"2011","unstructured":"Uchiyama T, Sakakibara R, Yamamoto T, Ito T, Yamaguchi C, Awa Y, Yanagisawa M, Higuchi Y, Sato Y, Ichikawa T, Yamanishi T, Hattori T, Kuwabara S (2011) Urinary dysfunction in early and untreated Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 82(12):1382\u20131386. \n                    https:\/\/doi.org\/10.1136\/jnnp.2011.241075","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"584_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10286-017-0480-0","volume":"28","author":"R Sakakibara","year":"2018","unstructured":"Sakakibara R, Tateno F, Yamamoto T, Uchiyama T, Yamanishi T (2018) Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management. Clin Auton Res 28(1):83\u2013101. \n                    https:\/\/doi.org\/10.1007\/s10286-017-0480-0","journal-title":"Clin Auton Res"},{"key":"584_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-017-0017-1","author":"P Borghammer","year":"2017","unstructured":"Borghammer P, Knudsen K, Fedorova TD, Brooks DJ (2017) Imaging Parkinson\u2019s disease below the neck. NPJ Parkinsons Dis. \n                    https:\/\/doi.org\/10.1038\/s41531-017-0017-1","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"584_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","volume":"20","author":"S Seki","year":"2001","unstructured":"Seki S, Igawa Y, Kaidoh K, Ishizuka O, Nishizawa O, Andersson KE (2001) Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol Urodyn 20(1):105\u2013113","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"584_CR49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1468-1331.2005.01087.x","volume":"12","author":"K Winge","year":"2005","unstructured":"Winge K, Friberg L, Werdelin L, Nielsen KK, Stimpel H (2005) Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson\u2019s disease. Eur J Neurol 12(11):842\u2013850. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01087.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"584_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol 124(5):643\u2013664. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1028-y","journal-title":"Acta Neuropathol"},{"issue":"1","key":"584_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ana.24430","volume":"78","author":"VG VanderHorst","year":"2015","unstructured":"VanderHorst VG, Samardzic T, Saper CB, Anderson MP, Nag S, Schneider JA, Bennett DA, Buchman AS (2015) alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol 78(1):142\u2013149. \n                    https:\/\/doi.org\/10.1002\/ana.24430","journal-title":"Ann Neurol"},{"key":"584_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/jpd-150686","volume":"5","author":"R Armstrong","year":"2015","unstructured":"Armstrong R (2015) Oculo-visual dysfunction in Parkinson\u2019s disease. J Parkinsons Dis 5:715\u2013726. \n                    https:\/\/doi.org\/10.3233\/jpd-150686","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"584_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/00207454.2010.526730","volume":"121","author":"E Giza","year":"2011","unstructured":"Giza E, Fotiou D, Bostantjopoulou S, Katsarou Z, Karlovasitou A (2011) Pupil light reflex in Parkinson\u2019s disease: evaluation with pupillometry. Int J Neurosci 121(1):37\u201343. \n                    https:\/\/doi.org\/10.3109\/00207454.2010.526730","journal-title":"Int J Neurosci"},{"issue":"2","key":"584_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijpsycho.2008.10.010","volume":"72","author":"V Stergiou","year":"2009","unstructured":"Stergiou V, Fotiou D, Tsiptsios D, Haidich B, Nakou M, Giantselidis C, Karlovasitou A (2009) Pupillometric findings in patients with Parkinson\u2019s disease and cognitive disorder. Int J Psychophysiol 72(2):97\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.ijpsycho.2008.10.010","journal-title":"Int J Psychophysiol"},{"issue":"3","key":"584_CR55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10286-009-0051-0","volume":"20","author":"F Yamashita","year":"2010","unstructured":"Yamashita F, Hirayama M, Nakamura T, Takamori M, Hori N, Uchida K, Hama T, Sobue G (2010) Pupillary autonomic dysfunction in multiple system atrophy and Parkinson\u2019s disease: an assessment by eye-drop tests. Clin Auton Res 20(3):191\u2013197. \n                    https:\/\/doi.org\/10.1007\/s10286-009-0051-0","journal-title":"Clin Auton Res"},{"issue":"1","key":"584_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00688956","volume":"68","author":"S Hunter","year":"1985","unstructured":"Hunter S (1985) The rostral mesencephalon in Parkinson\u2019s disease and Alzheimer\u2019s disease. Acta Neuropathol 68(1):53\u201358","journal-title":"Acta Neuropathol"},{"issue":"6","key":"584_CR57","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Del Tredici","year":"2010","unstructured":"Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol 119(6):703\u2013713. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0665-2","journal-title":"Acta Neuropathol"},{"issue":"11","key":"584_CR58","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","volume":"20","author":"P Srivanitchapoom","year":"2014","unstructured":"Srivanitchapoom P, Pandey S, Hallett M (2014) Drooling in Parkinson\u2019s disease: a review. Parkinsonism Relat Disord 20(11):1109\u20131118. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2014.08.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"584_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mds.20189","volume":"20","author":"M Proulx","year":"2005","unstructured":"Proulx M, de Courval FP, Wiseman MA, Panisset M (2005) Salivary production in Parkinson\u2019s disease. Mov Disord 20(2):204\u2013207. \n                    https:\/\/doi.org\/10.1002\/mds.20189","journal-title":"Mov Disord"},{"issue":"5","key":"584_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","volume":"18","author":"ZS Heetun","year":"2012","unstructured":"Heetun ZS, Quigley EM (2012) Gastroparesis and Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord 18(5):433\u2013440. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2011.12.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"5\u20136","key":"584_CR61","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1023\/A:1021844605250","volume":"22","author":"JH Pazo","year":"2002","unstructured":"Pazo JH, Belforte JE (2002) Basal ganglia and functions of the autonomic nervous system. Cell Mol Neurobiol 22(5\u20136):645\u2013654","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"584_CR62","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14(6):625\u2013639. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"issue":"7","key":"584_CR63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/NEN.0b013e3182965886","volume":"72","author":"L Mu","year":"2013","unstructured":"Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, Adler CH, Shill HA, Caviness JN, Samanta JE, Sue LI, Beach TG (2013) Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol 72(7):614\u2013623. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e3182965886","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1\u20132","key":"584_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2011.09.030","volume":"313","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE (2012) Autonomic involvement in Parkinson\u2019s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313(1\u20132):57\u201363. \n                    https:\/\/doi.org\/10.1016\/j.jns.2011.09.030","journal-title":"J Neurol Sci"},{"issue":"342","key":"584_CR65","doi-asserted-by":"publisher","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA, Hastings TG, Greenamyre JT (2016) alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8(342):342ra378. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaf3634","journal-title":"Sci Transl Med"},{"issue":"Pt 5","key":"584_CR66","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/brain\/aws086","volume":"135","author":"E Arai","year":"2012","unstructured":"Arai E, Arai M, Uchiyama T, Higuchi Y, Aoyagi K, Yamanaka Y, Yamamoto T, Nagano O, Shiina A, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Imazeki F, Saeki N, Kuwabara S, Yokosuka O (2012) Subthalamic deep brain stimulation can improve gastric emptying in Parkinson\u2019s disease. Brain 135(Pt 5):1478\u20131485. \n                    https:\/\/doi.org\/10.1093\/brain\/aws086","journal-title":"Brain"},{"issue":"1","key":"584_CR67","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41598-017-16790-8","volume":"8","author":"QJ Yu","year":"2018","unstructured":"Yu QJ, Yu SY, Zuo LJ, Lian TH, Hu Y, Wang RD, Piao YS, Guo P, Liu L, Jin Z, Li LX, Chan P, Chen SD, Wang XM, Zhang W (2018) Parkinson disease with constipation: clinical features and relevant factors. Sci Rep 8(1):567. \n                    https:\/\/doi.org\/10.1038\/s41598-017-16790-8","journal-title":"Sci Rep"},{"issue":"3","key":"584_CR68","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/jpd-171131","volume":"7","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Haase AM, Fedorova TD, Bekker AC, Ostergaard K, Krogh K, Borghammer P (2017) Gastrointestinal transit time in Parkinson\u2019s disease using a magnetic tracking system. J Parkinsons Dis 7(3):471\u2013479. \n                    https:\/\/doi.org\/10.3233\/jpd-171131","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"584_CR69","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/mcg.0000000000000469","volume":"50","author":"T Yu","year":"2016","unstructured":"Yu T, Wang Y, Wu G, Xu Q, Tang Y, Lin L (2016) High-resolution anorectal manometry in Parkinson disease with defecation disorder: a comparison with functional defecation disorder. J Clin Gastroenterol 50(7):566\u2013571. \n                    https:\/\/doi.org\/10.1097\/mcg.0000000000000469","journal-title":"J Clin Gastroenterol"},{"issue":"8979","key":"584_CR70","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","volume":"346","author":"C Singaram","year":"1995","unstructured":"Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM (1995) Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation. Lancet 346(8979):861\u2013864","journal-title":"Lancet"},{"issue":"5","key":"584_CR71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","volume":"124","author":"DM Annerino","year":"2012","unstructured":"Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG (2012) Parkinson\u2019s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124(5):665\u2013680. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1040-2","journal-title":"Acta Neuropathol"},{"issue":"4","key":"584_CR72","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/jpd-140422","volume":"4","author":"AG Corbille","year":"2014","unstructured":"Corbille AG, Coron E, Neunlist M, Derkinderen P, Lebouvier T (2014) Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD. J Parkinsons Dis 4(4):571\u2013576. \n                    https:\/\/doi.org\/10.3233\/jpd-140422","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"584_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-016-0408-2","volume":"5","author":"M Barrenschee","year":"2017","unstructured":"Barrenschee M, Zorenkov D, Bottner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T (2017) Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson\u2019s disease. Acta Neuropathol Commun 5(1):1. \n                    https:\/\/doi.org\/10.1186\/s40478-016-0408-2","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"584_CR74","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/mds.22360","volume":"24","author":"H Petrovitch","year":"2009","unstructured":"Petrovitch H, Abbott RD, Ross GW, Nelson J, Masaki KH, Tanner CM, Launer LJ, White LR (2009) Bowel movement frequency in late-life and substantia nigra neuron density at death. Mov Disord 24(3):371\u2013376. \n                    https:\/\/doi.org\/10.1002\/mds.22360","journal-title":"Mov Disord"},{"key":"584_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.08.010","author":"JT Hinkle","year":"2018","unstructured":"Hinkle JT, Perepezko K, Mills KA, Mari Z, Butala A, Dawson TM, Pantelyat A, Rosenthal LS, Pontone GM (2018) Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2018.08.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"584_CR76","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.410330512","volume":"33","author":"LL Edwards","year":"1993","unstructured":"Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF (1993) Defecatory function in Parkinson\u2019s disease: response to apomorphine. Ann Neurol 33(5):490\u2013493. \n                    https:\/\/doi.org\/10.1002\/ana.410330512","journal-title":"Ann Neurol"},{"issue":"12","key":"584_CR77","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/nmo.12933","volume":"28","author":"C Pellegrini","year":"2016","unstructured":"Pellegrini C, Colucci R, Antonioli L, Barocelli E, Ballabeni V, Bernardini N, Blandizzi C, de Jonge WJ, Fornai M (2016) Intestinal dysfunction in Parkinson\u2019s disease: lessons learned from translational studies and experimental models. Neurogastroenterol Motil 28(12):1781\u20131791. \n                    https:\/\/doi.org\/10.1111\/nmo.12933","journal-title":"Neurogastroenterol Motil"},{"key":"584_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5280","author":"BA Killinger","year":"2018","unstructured":"Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, Lindqvist D, Chen H, Thomas PM, Brundin P, Brundin L, Labrie V (2018) The vermiform appendix impacts the risk of developing Parkinson\u2019s disease. Sci Transl Med. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aar5280","journal-title":"Sci Transl Med"},{"key":"584_CR79","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:155. \n                    https:\/\/doi.org\/10.3389\/fnana.2014.00155","journal-title":"Front Neuroanat"},{"key":"584_CR80","doi-asserted-by":"publisher","DOI":"10.5772\/63328","volume-title":"Challenges in Parkinson\u2019s Disease","author":"J Blesa","year":"2016","unstructured":"Blesa J, Trigo\u2010Damas I, Quiroga\u2010Varela A, Rey NLGd (2016) Animal Models of Parkinson\u2019s Disease. In: Kozubski JDaW (ed) Challenges in Parkinson\u2019s Disease. IntechOpen, London. \n                    https:\/\/doi.org\/10.5772\/63328"},{"key":"584_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove J, Perier C (2012) Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience 211:51\u201376. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.057","journal-title":"Neuroscience"},{"issue":"4","key":"584_CR82","doi-asserted-by":"publisher","first-page":"e35371","DOI":"10.1371\/journal.pone.0035371","volume":"7","author":"V Joers","year":"2012","unstructured":"Joers V, Seneczko K, Goecks NC, Kamp TJ, Hacker TA, Brunner KG, Engle JW, Barnhart TE, Nickles RJ, Holden JE, Emborg ME (2012) Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One 7(4):e35371. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035371","journal-title":"PLoS One"},{"key":"584_CR83","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/B978-0-12-811353-0.00046-4","volume-title":"Conn\u2019s Handbook of Models for Human Aging","author":"JM Metzger","year":"2018","unstructured":"Metzger JM, Jones CA, Emborg ME (2018) Parkinson\u2019s disease in humans and in non-human primate aging and neurotoxin models. In: Conn JRaPM (ed) Conn\u2019s Handbook of Models for Human Aging, 2nd edn. Academic Press, London, pp 617\u2013640","edition":"2"},{"key":"584_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson ME, Bobrovskaya L (2015) An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 46:101\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","journal-title":"Neurotoxicology"},{"issue":"1","key":"584_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","volume":"88","author":"JR Richardson","year":"2005","unstructured":"Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88(1):193\u2013201. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfi304","journal-title":"Toxicol Sci"},{"issue":"1","key":"584_CR86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","volume":"103","author":"J Rodriguez-Pallares","year":"2007","unstructured":"Rodriguez-Pallares J, Parga JA, Mu\u00f1oz A, Rey P, Guerra MJ, Labandeira-Garcia JL (2007) Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem 103(1):145\u2013156. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04699.x","journal-title":"J Neurochem"},{"issue":"1","key":"584_CR87","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/jpd-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis 1(1):19\u201333. \n                    https:\/\/doi.org\/10.3233\/jpd-2011-11023","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"584_CR88","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","volume":"20","author":"MG Purisai","year":"2005","unstructured":"Purisai MG, McCormack AL, Langston WJ, Johnston LC, Di Monte DA (2005) Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 20(3):898\u2013906. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2005.05.028","journal-title":"Neurobiol Dis"},{"issue":"1","key":"584_CR89","first-page":"211","volume":"11","author":"NW Kowall","year":"2000","unstructured":"Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuro Rep 11(1):211\u2013213","journal-title":"Neuro Rep"},{"issue":"2","key":"584_CR90","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","volume":"22","author":"R Betarbet","year":"2006","unstructured":"Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Yagi A, Klinefelter G, Cookson MR, Greenamyre JT (2006) Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 22(2):404\u2013420. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2005.12.003","journal-title":"Neurobiol Dis"},{"issue":"5321","key":"584_CR91","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"11","key":"584_CR92","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95(11):6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"584_CR93","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","volume":"274","author":"L Narhi","year":"1999","unstructured":"Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M (1999) Both familial Parkinson\u2019s disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274(14):9843\u20139846","journal-title":"J Biol Chem"},{"key":"584_CR94","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. \n                    https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"issue":"5","key":"584_CR95","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14(5):504\u2013506. \n                    https:\/\/doi.org\/10.1038\/nm1747","journal-title":"Nat Med"},{"issue":"5","key":"584_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14(5):501\u2013503. \n                    https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"issue":"41","key":"584_CR97","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1523\/jneurosci.1788-16.2017","volume":"37","author":"P Brundin","year":"2017","unstructured":"Brundin P, Melki R (2017) Prying into the prion hypothesis for Parkinson\u2019s disease. J Neurosci 37(41):9808\u20139818. \n                    https:\/\/doi.org\/10.1523\/jneurosci.1788-16.2017","journal-title":"J Neurosci"},{"issue":"1","key":"584_CR98","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00441-017-2730-9","volume":"373","author":"A Recasens","year":"2018","unstructured":"Recasens A, Ulusoy A, Kahle PJ, Di Monte DA, Dehay B (2018) In vivo models of alpha-synuclein transmission and propagation. Cell Tissue Res 373(1):183\u2013193. \n                    https:\/\/doi.org\/10.1007\/s00441-017-2730-9","journal-title":"Cell Tissue Res"},{"issue":"19","key":"584_CR99","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/0006-2952(84)90593-8","volume":"33","author":"RW Fuller","year":"1984","unstructured":"Fuller RW, Hahn RA, Snoddy HD, Wikel JH (1984) Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 33(19):2957\u20132960","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"584_CR100","first-page":"125","volume":"4","author":"V Joers","year":"2014","unstructured":"Joers V, Emborg ME (2014) Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson\u2019s disease. Am J Nucl Med Mol Imaging 4(2):125\u2013159","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"7","key":"584_CR101","doi-asserted-by":"publisher","first-page":"e0133971","DOI":"10.1371\/journal.pone.0133971","volume":"10","author":"YH Jiang","year":"2015","unstructured":"Jiang YH, Jiang P, Yang JL, Ma DF, Lin HQ, Su WG, Wang Z, Li X (2015) Cardiac dysregulation and myocardial injury in a 6-hydroxydopamine-induced rat model of sympathetic denervation. PLoS One 10(7):e0133971. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0133971","journal-title":"PLoS One"},{"issue":"5","key":"584_CR102","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00004872-199105000-00005","volume":"9","author":"DS Goldstein","year":"1991","unstructured":"Goldstein DS, Grossman E, Tamrat M, Chang PC, Eisenhofer G, Bacher J, Kirk KL, Bacharach S, Kopin IJ (1991) Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertens 9(5):417\u2013423","journal-title":"J Hypertens"},{"issue":"8","key":"584_CR103","doi-asserted-by":"publisher","first-page":"e104850","DOI":"10.1371\/journal.pone.0104850","volume":"9","author":"V Joers","year":"2014","unstructured":"Joers V, Dilley K, Rahman S, Jones C, Shultz J, Simmons H, Emborg ME (2014) Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates. PLoS One 9(8):e104850. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0104850","journal-title":"PLoS One"},{"key":"584_CR104","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41531-018-0057-1","volume":"4","author":"JM Metzger","year":"2018","unstructured":"Metzger JM, Moore CF, Boettcher CA, Brunner KG, Fleddermann RA, Matsoff HN, Resnikoff HA, Bondarenko V, Kamp TJ, Hacker TA, Barnhart TE, Lao PJ, Christian BT, Nickles RJ, Gallagher CL, Holden JE, Emborg ME (2018) In vivo imaging of inflammation and oxidative stress in a nonhuman primate model of cardiac sympathetic neurodegeneration. NPJ Parkinsons Dis 4:22. \n                    https:\/\/doi.org\/10.1038\/s41531-018-0057-1","journal-title":"NPJ Parkinsons Dis"},{"key":"584_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2015.09.024","volume":"607","author":"D Ariza","year":"2015","unstructured":"Ariza D, Lopes FN, Crestani CC, Martins-Pinge MC (2015) Chemoreflex and baroreflex alterations in Parkinsonism induced by 6-OHDA in unanesthetized rats. Neurosci Lett 607:77\u201382. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2015.09.024","journal-title":"Neurosci Lett"},{"key":"584_CR106","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lfs.2015.01.032","volume":"127","author":"AS Silva","year":"2015","unstructured":"Silva AS, Ariza D, Dias DP, Crestani CC, Martins-Pinge MC (2015) Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA. Life Sci 127:82\u201389. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2015.01.032","journal-title":"Life Sci"},{"issue":"1","key":"584_CR107","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1254\/jphs.08144FP","volume":"108","author":"JG Yu","year":"2008","unstructured":"Yu JG, Wu J, Shen FM, Cai GJ, Liu JG, Su DF (2008) Arterial baroreflex dysfunction fails to mimic Parkinson\u2019s disease in rats. J Pharmacol Sci 108(1):56\u201362","journal-title":"J Pharmacol Sci"},{"issue":"13","key":"584_CR108","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0024-3205(00)00751-7","volume":"67","author":"V Ben","year":"2000","unstructured":"Ben V, Bruguerolle B (2000) Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci 67(13):1549\u20131558","journal-title":"Life Sci"},{"issue":"2","key":"584_CR109","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/07420521003664213","volume":"27","author":"A Boulamery","year":"2010","unstructured":"Boulamery A, Simon N, Vidal J, Bruguerolle B (2010) Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. Chronobiol Int 27(2):251\u2013264. \n                    https:\/\/doi.org\/10.3109\/07420521003664213","journal-title":"Chronobiol Int"},{"key":"584_CR110","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2016.12.008","volume":"1657","author":"B Falquetto","year":"2017","unstructured":"Falquetto B, Tuppy M, Potje SR, Moreira TS, Antoniali C, Takakura AC (2017) Cardiovascular dysfunction associated with neurodegeneration in an experimental model of Parkinson\u2019s disease. Brain Res 1657:156\u2013166. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2016.12.008","journal-title":"Brain Res"},{"issue":"1\u20132","key":"584_CR111","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0006-8993(01)03402-3","volume":"928","author":"M Sakata","year":"2002","unstructured":"Sakata M, Sei H, Toida K, Fujihara H, Urushihara R, Morita Y (2002) Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation. Brain Res 928(1\u20132):194\u2013201","journal-title":"Brain Res"},{"issue":"6","key":"584_CR112","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1111\/ejn.13012","volume":"42","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Du X, Xu H, Xie J, Jiang H (2015) Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone-induced Parkinson\u2019s disease rats. Eur J Neurosci 42(6):2346\u20132355. \n                    https:\/\/doi.org\/10.1111\/ejn.13012","journal-title":"Eur J Neurosci"},{"issue":"2","key":"584_CR113","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","volume":"47","author":"PJ Hallett","year":"2012","unstructured":"Hallett PJ, McLean JR, Kartunen A, Langston JW, Isacson O (2012) alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol Dis 47(2):258\u2013267. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.04.009","journal-title":"Neurobiol Dis"},{"key":"584_CR114","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fneur.2013.00103","volume":"4","author":"SM Fleming","year":"2013","unstructured":"Fleming SM, Jordan MC, Mulligan CK, Masliah E, Holden JG, Millard RW, Chesselet MF, Roos KP (2013) Impaired baroreflex function in mice overexpressing alpha-synuclein. Front Neurol 4:103. \n                    https:\/\/doi.org\/10.3389\/fneur.2013.00103","journal-title":"Front Neurol"},{"issue":"3","key":"584_CR115","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.neurobiolaging.2012.07.008","volume":"34","author":"KJ Griffioen","year":"2013","unstructured":"Griffioen KJ, Rothman SM, Ladenheim B, Wan R, Vranis N, Hutchison E, Okun E, Cadet JL, Mattson MP (2013) Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant alpha-synuclein. Neurobiol Aging 34(3):928\u2013935. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.07.008","journal-title":"Neurobiol Aging"},{"issue":"9","key":"584_CR116","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19(9):1633\u20131650. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddq038","journal-title":"Hum Mol Genet"},{"issue":"15","key":"584_CR117","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.1303444110","volume":"110","author":"F Billia","year":"2013","unstructured":"Billia F, Hauck L, Grothe D, Konecny F, Rao V, Kim RH, Mak TW (2013) Parkinson-susceptibility gene DJ-1\/PARK7 protects the murine heart from oxidative damage in vivo. Proc Natl Acad Sci USA 110(15):6085\u20136090. \n                    https:\/\/doi.org\/10.1073\/pnas.1303444110","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR118","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.bbabio.2016.03.014","volume":"8","author":"GW Dorn","year":"1857","unstructured":"Dorn GW (1857) 2nd (2016) central Parkin: the evolving role of Parkin in the heart. Biochim Biophys Acta 8:1307\u20131312. \n                    https:\/\/doi.org\/10.1016\/j.bbabio.2016.03.014","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"584_CR119","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1073\/pnas.1106291108","volume":"108","author":"F Billia","year":"2011","unstructured":"Billia F, Hauck L, Konecny F, Rao V, Shen J, Mak TW (2011) PTEN-inducible kinase 1 (PINK1)\/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA 108(23):9572\u20139577. \n                    https:\/\/doi.org\/10.1073\/pnas.1106291108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"584_CR120","doi-asserted-by":"publisher","first-page":"e80705","DOI":"10.1371\/journal.pone.0080705","volume":"8","author":"MA Baptista","year":"2013","unstructured":"Baptista MA, Dave KD, Frasier MA, Sherer TB, Greeley M, Beck MJ, Varsho JS, Parker GA, Moore C, Churchill MJ, Meshul CK, Fiske BK (2013) Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs. PLoS One 8(11):e80705. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0080705","journal-title":"PLoS One"},{"issue":"2","key":"584_CR121","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0014-2999(87)90277-9","volume":"141","author":"S Algeri","year":"1987","unstructured":"Algeri S, Ambrosio S, Garofalo P, Gerli P (1987) Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP\u2009+) in the rat. Eur J Pharmacol 141(2):309\u2013312","journal-title":"Eur J Pharmacol"},{"key":"584_CR122","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jchemneu.2015.11.002","volume":"70","author":"ME Johnson","year":"2015","unstructured":"Johnson ME, Lim Y, Senthilkumaran M, Zhou XF, Bobrovskaya L (2015) Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson\u2019s disease. J Chem Neuroanat 70:33\u201341. \n                    https:\/\/doi.org\/10.1016\/j.jchemneu.2015.11.002","journal-title":"J Chem Neuroanat"},{"issue":"4","key":"584_CR123","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jnc.12481","volume":"128","author":"KF Farrell","year":"2014","unstructured":"Farrell KF, Krishnamachari S, Villanueva E, Lou H, Alerte TN, Peet E, Drolet RE, Perez RG (2014) Non-motor parkinsonian pathology in aging A53T alpha-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function. J Neurochem 128(4):536\u2013546. \n                    https:\/\/doi.org\/10.1111\/jnc.12481","journal-title":"J Neurochem"},{"issue":"1","key":"584_CR124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0028-3908(94)00109-6","volume":"34","author":"C Suaudeau","year":"1995","unstructured":"Suaudeau C, Dourmap N, Costentin J (1995) Rapid and long lasting reduction of the hypothermic effect of a D2 dopamine agonist after an intracerebroventricular injection of 6-hydroxydopamine. Neuropharmacology 34(1):101\u2013105","journal-title":"Neuropharmacology"},{"issue":"2","key":"584_CR125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/jpd-140424","volume":"5","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Dou Y, Lockwood G, Pani A, Jay Smeyne R (2015) Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or paraquat on core temperature in C57BL\/6\u00a0J mice. J Parkinsons Dis 5(2):389\u2013401. \n                    https:\/\/doi.org\/10.3233\/jpd-140424","journal-title":"J Parkinsons Dis"},{"issue":"32","key":"584_CR126","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1073\/pnas.1511680112","volume":"112","author":"YG Kamberov","year":"2015","unstructured":"Kamberov YG, Karlsson EK, Kamberova GL, Lieberman DE, Sabeti PC, Morgan BA, Tabin CJ (2015) A genetic basis of variation in eccrine sweat gland and hair follicle density. Proc Natl Acad Sci USA 112(32):9932\u20139937. \n                    https:\/\/doi.org\/10.1073\/pnas.1511680112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"584_CR127","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cne.903460412","volume":"346","author":"MS Rao","year":"1994","unstructured":"Rao MS, Jaszczak E, Landis SC (1994) Innervation of footpads of normal and mutant mice lacking sweat glands. J Comp Neurol 346(4):613\u2013625. \n                    https:\/\/doi.org\/10.1002\/cne.903460412","journal-title":"J Comp Neurol"},{"issue":"6","key":"584_CR128","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1523\/JNEUROSCI.04-06-01535.1984","volume":"4","author":"ML Yodlowski","year":"1984","unstructured":"Yodlowski ML, Fredieu JR, Landis SC (1984) Neonatal 6-hydroxydopamine treatment eliminates cholinergic sympathetic innervation and induces sensory sprouting in rat sweat glands. J Neurosci 4(6):1535\u20131548","journal-title":"J Neurosci"},{"issue":"1","key":"584_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/nau.20917","volume":"30","author":"R Soler","year":"2011","unstructured":"Soler R, Fullhase C, Santos C, Andersson KE (2011) Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol Urodyn 30(1):188\u2013193. \n                    https:\/\/doi.org\/10.1002\/nau.20917","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"584_CR130","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","volume":"139","author":"N Yoshimura","year":"2003","unstructured":"Yoshimura N, Kuno S, Chancellor MB, De Groat WC, Seki S (2003) Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br J Pharmacol 139(8):1425\u20131432. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0705388","journal-title":"Br J Pharmacol"},{"issue":"5","key":"584_CR131","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.juro.2015.11.039","volume":"195","author":"T Kitta","year":"2016","unstructured":"Kitta T, Chancellor MB, de Groat WC, Shinohara N, Yoshimura N (2016) Role of the anterior cingulate cortex in the control of micturition reflex in a rat model of Parkinson\u2019s disease. J Urol 195(5):1613\u20131620. \n                    https:\/\/doi.org\/10.1016\/j.juro.2015.11.039","journal-title":"J Urol"},{"issue":"3","key":"584_CR132","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.juro.2013.08.026","volume":"191","author":"L Campeau","year":"2014","unstructured":"Campeau L, Soler R, Sittadjody S, Pareta R, Nomiya M, Zarifpour M, Opara EC, Yoo JJ, Andersson KE (2014) Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease. J Urol 191(3):850\u2013859. \n                    https:\/\/doi.org\/10.1016\/j.juro.2013.08.026","journal-title":"J Urol"},{"issue":"1\u20132","key":"584_CR133","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0304-3940(88)90143-7","volume":"87","author":"A Albanese","year":"1988","unstructured":"Albanese A, Jenner P, Marsden CD, Stephenson JD (1988) Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett 87(1\u20132):46\u201350","journal-title":"Neurosci Lett"},{"issue":"1","key":"584_CR134","first-page":"228","volume":"286","author":"N Yoshimura","year":"1998","unstructured":"Yoshimura N, Mizuta E, Yoshida O, Kuno S (1998) Therapeutic effects of dopamine D1\/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J Pharmacol Exp Ther 286(1):228\u2013233","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"584_CR135","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/jpd-140509","volume":"5","author":"R Mitra","year":"2015","unstructured":"Mitra R, Aronsson P, Winder M, Tobin G, Bergquist F, Carlsson T (2015) Local change in urinary bladder contractility following CNS dopamine denervation in the 6-OHDA rat model of Parkinson\u2019s disease. J Parkinsons Dis 5(2):301\u2013311. \n                    https:\/\/doi.org\/10.3233\/jpd-140509","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"584_CR136","doi-asserted-by":"publisher","first-page":"e0175797","DOI":"10.1371\/journal.pone.0175797","volume":"12","author":"S Pritchard","year":"2017","unstructured":"Pritchard S, Jackson MJ, Hikima A, Lione L, Benham CD, Chaudhuri KR, Rose S, Jenner P, Iravani MM (2017) Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia. PLoS One 12(5):e0175797. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0175797","journal-title":"PLoS One"},{"issue":"6","key":"584_CR137","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/dneu.20978","volume":"72","author":"RW Hamill","year":"2012","unstructured":"Hamill RW, Tompkins JD, Girard BM, Kershen RT, Parsons RL, Vizzard MA (2012) Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice. Dev Neurobiol 72(6):918\u2013936. \n                    https:\/\/doi.org\/10.1002\/dneu.20978","journal-title":"Dev Neurobiol"},{"issue":"8\u20139","key":"584_CR138","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1177\/0301006615596868","volume":"44","author":"LV Tereshchenko","year":"2015","unstructured":"Tereshchenko LV, Anisimov VN, Shul\u2019govsky VV, Latanov AV (2015) Early changes in saccadic eye movement in hemiparkinsonian MPTP-treated monkeys. Perception 44(8\u20139):1054\u20131063. \n                    https:\/\/doi.org\/10.1177\/0301006615596868","journal-title":"Perception"},{"issue":"4","key":"584_CR139","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0091-3057(91)90255-Z","volume":"38","author":"MS Lawrence","year":"1991","unstructured":"Lawrence MS, Redmond DE Jr (1991) MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacol Biochem Behav 38(4):869\u2013874","journal-title":"Pharmacol Biochem Behav"},{"issue":"13","key":"584_CR140","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1167\/iovs.16-19543","volume":"57","author":"XH Wu","year":"2016","unstructured":"Wu XH, Qian KW, Xu GZ, Li YY, Ma YY, Huang F, Wang YQ, Zhou X, Qu J, Yang XL, Zhong YM, Weng SJ (2016) The role of retinal dopamine in C57BL\/6 mouse refractive development as revealed by intravitreal administration of 6-hydroxydopamine. Invest Ophthalmol Vis Sci 57(13):5393\u20135404. \n                    https:\/\/doi.org\/10.1167\/iovs.16-19543","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"584_CR141","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cne.20761","volume":"493","author":"N Cuenca","year":"2005","unstructured":"Cuenca N, Herrero MT, Angulo A, de Juan E, Martinez-Navarrete GC, Lopez S, Barcia C, Martin-Nieto J (2005) Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson\u2019s disease. J Comp Neurol 493(2):261\u2013273. \n                    https:\/\/doi.org\/10.1002\/cne.20761","journal-title":"J Comp Neurol"},{"issue":"3","key":"584_CR142","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1469-7580.2005.00390.x","volume":"206","author":"C Cavallotti","year":"2005","unstructured":"Cavallotti C, Frati A, Sagnelli P, Pescosolido N (2005) Re-evaluation and quantification of the different sources of nerve fibres supplying the rat eye. J Anat 206(3):217\u2013224. \n                    https:\/\/doi.org\/10.1111\/j.1469-7580.2005.00390.x","journal-title":"J Anat"},{"issue":"1","key":"584_CR143","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0378-4274(90)90059-U","volume":"54","author":"J Luthman","year":"1990","unstructured":"Luthman J, Sundstrom E (1990) No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57 BL\/6 mice. Toxicol Lett 54(1):83\u201392","journal-title":"Toxicol Lett"},{"issue":"Pt 1","key":"584_CR144","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/brain\/111.1.131","volume":"111","author":"MF Ghilardi","year":"1988","unstructured":"Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA (1988) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111(Pt 1):131\u2013149","journal-title":"Brain"},{"issue":"8","key":"584_CR145","first-page":"1067","volume":"10","author":"BK Colasanti","year":"1978","unstructured":"Colasanti BK, Kosa JE, Trotter RR (1978) Responsiveness of the rabbit eye to adrenergic and cholinergic agonists after treatment with 6-hydroxydopamine or alpha-methyl-para-tyrosine: part I-Pupillary changes. Ann Ophthalmol 10(8):1067\u20131074","journal-title":"Ann Ophthalmol"},{"issue":"4","key":"584_CR146","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410250407","volume":"25","author":"MF Ghilardi","year":"1989","unstructured":"Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA (1989) The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 25(4):357\u2013364. \n                    https:\/\/doi.org\/10.1002\/ana.410250407","journal-title":"Ann Neurol"},{"issue":"1","key":"584_CR147","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jnr.1129","volume":"65","author":"A Surguchov","year":"2001","unstructured":"Surguchov A, McMahan B, Masliah E, Surgucheva I (2001) Synucleins in ocular tissues. J Neurosci Res 65(1):68\u201377. \n                    https:\/\/doi.org\/10.1002\/jnr.1129","journal-title":"J Neurosci Res"},{"key":"584_CR148","doi-asserted-by":"publisher","first-page":"29523","DOI":"10.1038\/srep29523","volume":"6","author":"DL Price","year":"2016","unstructured":"Price DL, Rockenstein E, Mante M, Adame A, Overk C, Spencer B, Duong-Polk KX, Bonhaus D, Lindsey J, Masliah E (2016) Longitudinal live imaging of retinal alpha-synuclein:GFP deposits in a transgenic mouse model of Parkinson\u2019s disease\/dementia with lewy bodies. Sci Rep 6:29523. \n                    https:\/\/doi.org\/10.1038\/srep29523","journal-title":"Sci Rep"},{"issue":"2","key":"584_CR149","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbr.2012.07.003","volume":"234","author":"AL Nuckolls","year":"2012","unstructured":"Nuckolls AL, Worley C, Leto C, Zhang H, Morris JK, Stanford JA (2012) Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats. Behav Brain Res 234(2):343\u2013348. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2012.07.003","journal-title":"Behav Brain Res"},{"key":"584_CR150","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-018-9896-5","author":"KP Cullen","year":"2018","unstructured":"Cullen KP, Grant LM, Kelm-Nelson CA, Brauer AFL, Bickelhaupt LB, Russell JA, Ciucci MR (2018) Pink1 -\/- rats show early-onset swallowing deficits and correlative brainstem pathology. Dysphagia. \n                    https:\/\/doi.org\/10.1007\/s00455-018-9896-5","journal-title":"Dysphagia"},{"key":"584_CR151","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2017.10.036","volume":"339","author":"KM Yang","year":"2018","unstructured":"Yang KM, Blue KV, Mulholland HM, Kurup MP, Kelm-Nelson CA, Ciucci MR (2018) Characterization of oromotor and limb motor dysfunction in the DJ1 -\/- model of Parkinson disease. Behav Brain Res 339:47\u201356. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2017.10.036","journal-title":"Behav Brain Res"},{"key":"584_CR152","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2011.09.006","volume":"1420","author":"LF Zheng","year":"2011","unstructured":"Zheng LF, Wang ZY, Li XF, Song J, Hong F, Lian H, Wang Q, Feng XY, Tang YY, Zhang Y, Zhu JX (2011) Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson\u2019s disease. Brain Res 1420:59\u201367. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2011.09.006","journal-title":"Brain Res"},{"key":"584_CR153","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898. \n                    https:\/\/doi.org\/10.1038\/srep00898","journal-title":"Sci Rep"},{"issue":"2","key":"584_CR154","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/apha.12229","volume":"211","author":"LF Zheng","year":"2014","unstructured":"Zheng LF, Song J, Fan RF, Chen CL, Ren QZ, Zhang XL, Feng XY, Zhang Y, Li LS, Zhu JX (2014) The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra. Acta Physiol (Oxf) 211(2):434\u2013446. \n                    https:\/\/doi.org\/10.1111\/apha.12229","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"584_CR155","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12031-011-9560-0","volume":"47","author":"HC Zhu","year":"2012","unstructured":"Zhu HC, Zhao J, Luo CY, Li QQ (2012) Gastrointestinal dysfunction in a Parkinson\u2019s disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci 47(1):15\u201325. \n                    https:\/\/doi.org\/10.1007\/s12031-011-9560-0","journal-title":"J Mol Neurosci"},{"issue":"10","key":"584_CR156","doi-asserted-by":"publisher","first-page":"G1013","DOI":"10.1152\/ajpgi.00258.2014","volume":"307","author":"L Toti","year":"2014","unstructured":"Toti L, Travagli RA (2014) Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. Am J Physiol Gastrointest Liver Physiol 307(10):G1013\u20131023. \n                    https:\/\/doi.org\/10.1152\/ajpgi.00258.2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"584_CR157","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1053\/j.gastro.2017.08.069","volume":"153","author":"L Anselmi","year":"2017","unstructured":"Anselmi L, Toti L, Bove C, Hampton J, Travagli RA (2017) A Nigro\u2013vagal pathway controls gastric motility and is affected in a rat model of parkinsonism. Gastroenterology 153(6):1581\u20131593. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2017.08.069","journal-title":"Gastroenterology"},{"issue":"3","key":"584_CR158","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neuroscience.2008.02.033","volume":"153","author":"YM Tian","year":"2008","unstructured":"Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX (2008) Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson\u2019s disease. Neuroscience 153(3):634\u2013644. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2008.02.033","journal-title":"Neuroscience"},{"issue":"1","key":"584_CR159","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","volume":"207","author":"G Anderson","year":"2007","unstructured":"Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S, Greene JG (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 207(1):4\u201312. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2007.05.010","journal-title":"Exp Neurol"},{"issue":"1","key":"584_CR160","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","volume":"218","author":"JG Greene","year":"2009","unstructured":"Greene JG, Noorian AR, Srinivasan S (2009) Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson\u2019s disease. Exp Neurol 218(1):154\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2009.04.023","journal-title":"Exp Neurol"},{"issue":"3","key":"584_CR161","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1111\/nmo.12070","volume":"25","author":"M Tasselli","year":"2013","unstructured":"Tasselli M, Chaumette T, Paillusson S, Monnet Y, Lafoux A, Huchet-Cadiou C, Aubert P, Hunot S, Derkinderen P, Neunlist M (2013) Effects of oral administration of rotenone on gastrointestinal functions in mice. Neurogastroenterol Motil 25(3):e183\u2013193. \n                    https:\/\/doi.org\/10.1111\/nmo.12070","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"584_CR162","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5(1):e8762. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0008762","journal-title":"PLoS One"},{"key":"584_CR163","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-018-0066-0","volume":"4","author":"L Anselmi","year":"2018","unstructured":"Anselmi L, Bove C, Coleman FH, Le K, Subramanian MP, Venkiteswaran K, Subramanian T, Travagli RA (2018) Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinsons Dis 4:30. \n                    https:\/\/doi.org\/10.1038\/s41531-018-0066-0","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"584_CR164","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2012.06.005","volume":"48","author":"AR Noorian","year":"2012","unstructured":"Noorian AR, Rha J, Annerino DM, Bernhard D, Taylor GM, Greene JG (2012) Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system. Neurobiol Dis 48(1):9\u201319. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.06.005","journal-title":"Neurobiol Dis"},{"issue":"9","key":"584_CR165","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","volume":"24","author":"L Wang","year":"2012","unstructured":"Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF, Tach\u00e9 Y (2012) Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterol Motil 24(9):e425\u2013436. \n                    https:\/\/doi.org\/10.1111\/j.1365-2982.2012.01974.x","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"584_CR166","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9(2):297\u2013314. \n                    https:\/\/doi.org\/10.1007\/s13311-012-0104-2","journal-title":"Neurotherapeutics"},{"issue":"6","key":"584_CR167","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805\u2013820. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1343-6","journal-title":"Acta Neuropathol"},{"issue":"1","key":"584_CR168","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13(1):21. \n                    https:\/\/doi.org\/10.1186\/s13024-018-0257-5","journal-title":"Mol Neurodegener"},{"issue":"2","key":"584_CR169","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1124\/jpet.115.228510","volume":"356","author":"M Fornai","year":"2016","unstructured":"Fornai M, Pellegrini C, Antonioli L, Segnani C, Ippolito C, Barocelli E, Ballabeni V, Vegezzi G, Al Harraq Z, Blandini F, Levandis G, Cerri S, Blandizzi C, Bernardini N, Colucci R (2016) Enteric dysfunctions in experimental Parkinson\u2019s disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats. J Pharmacol Exp Ther 356(2):434\u2013444. \n                    https:\/\/doi.org\/10.1124\/jpet.115.228510","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"584_CR170","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/nmo.12691","volume":"27","author":"G Levandis","year":"2015","unstructured":"Levandis G, Balestra B, Siani F, Rizzo V, Ghezzi C, Ambrosi G, Cerri S, Bonizzi A, Vicini R, Vairetti M, Ferrigno A, Pastoris O, Blandini F (2015) Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson\u2019s disease. Neurogastroenterol Motil 27(12):1783\u20131795. \n                    https:\/\/doi.org\/10.1111\/nmo.12691","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"584_CR171","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.autneu.2012.04.005","volume":"169","author":"M Colucci","year":"2012","unstructured":"Colucci M, Cervio M, Faniglione M, De Angelis S, Pajoro M, Levandis G, Tassorelli C, Blandini F, Feletti F, De Giorgio R, Dellabianca A, Tonini S, Tonini M (2012) Intestinal dysmotility and enteric neurochemical changes in a Parkinson\u2019s disease rat model. Auton Neurosci 169(2):77\u201386. \n                    https:\/\/doi.org\/10.1016\/j.autneu.2012.04.005","journal-title":"Auton Neurosci"},{"issue":"3","key":"584_CR172","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neulet.2009.10.035","volume":"467","author":"F Blandini","year":"2009","unstructured":"Blandini F, Balestra B, Levandis G, Cervio M, Greco R, Tassorelli C, Colucci M, Faniglione M, Bazzini E, Nappi G, Clavenzani P, Vigneri S, De Giorgio R, Tonini M (2009) Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson\u2019s disease. Neurosci Lett 467(3):203\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2009.10.035","journal-title":"Neurosci Lett"},{"issue":"2","key":"584_CR173","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.trsl.2015.02.003","volume":"166","author":"X Zhang","year":"2015","unstructured":"Zhang X, Li Y, Liu C, Fan R, Wang P, Zheng L, Hong F, Feng X, Zhang Y, Li L, Zhu J (2015) Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson\u2019s disease rats. Transl Res 166(2):152\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2015.02.003","journal-title":"Transl Res"},{"key":"584_CR174","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","volume":"294","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun JD, Song LK, Li J, Chu SF, Yuan YH, Chen NH (2015) Environment-contact administration of rotenone: a new rodent model of Parkinson\u2019s disease. Behav Brain Res 294:149\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2015.07.058","journal-title":"Behav Brain Res"},{"issue":"3","key":"584_CR175","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10286-016-0358-6","volume":"26","author":"M Arnhold","year":"2016","unstructured":"Arnhold M, Dening Y, Chopin M, Arevalo E, Schwarz M, Reichmann H, Gille G, Funk RH, Pan-Montojo F (2016) Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson\u2019s disease. Clin Auton Res 26(3):211\u2013222. \n                    https:\/\/doi.org\/10.1007\/s10286-016-0358-6","journal-title":"Clin Auton Res"},{"key":"584_CR176","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-018-2620-x","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H, Gao J, Jia Y, Bai Q (2018) Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. Neurochem Res. \n                    https:\/\/doi.org\/10.1007\/s11064-018-2620-x","journal-title":"Neurochem Res"},{"key":"584_CR177","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000279","author":"JM Shultz","year":"2016","unstructured":"Shultz JM, Resnikoff H, Bondarenko V, Joers V, Meija A, Simmons H, Emborg ME (2016) Neurotoxin-induced catecholaminergic loss in the colonic myenteric plexus of rhesus monkeys. J Alzheimers Dis Parkinsonism. \n                    https:\/\/doi.org\/10.4172\/2161-0460.1000279","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"584_CR178","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","volume":"1355","author":"G Natale","year":"2010","unstructured":"Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F (2010) MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 1355:195\u2013206. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2010.07.076","journal-title":"Brain Res"},{"key":"584_CR179","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.1038\/srep30269","volume":"6","author":"LJ Ellett","year":"2016","unstructured":"Ellett LJ, Hung LW, Munckton R, Sherratt NA, Culvenor J, Grubman A, Furness JB, White AR, Finkelstein DI, Barnham KJ, Lawson VA (2016) Restoration of intestinal function in an MPTP model of Parkinson\u2019s disease. Sci Rep 6:30269. \n                    https:\/\/doi.org\/10.1038\/srep30269","journal-title":"Sci Rep"},{"key":"584_CR180","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2017","unstructured":"Yang X, Qian Y, Xu S, Song Y, Xiao Q (2017) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease. Front Aging Neurosci 9:441. \n                    https:\/\/doi.org\/10.3389\/fnagi.2017.00441","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"584_CR181","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","volume":"19","author":"L Wang","year":"2008","unstructured":"Wang L, Fleming SM, Chesselet MF, Tache Y (2008) Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuro Rep 19(8):873\u2013876. \n                    https:\/\/doi.org\/10.1097\/WNR.0b013e3282ffda5e","journal-title":"Neuro Rep"},{"issue":"39","key":"584_CR182","doi-asserted-by":"publisher","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","volume":"291","author":"G Vidal-Martinez","year":"2016","unstructured":"Vidal-Martinez G, Vargas-Medrano J, Gil-Tommee C, Medina D, Garza NT, Yang B, Segura-Ulate I, Dominguez SJ, Perez RG (2016) FTY720\/fingolimod reduces synucleinopathy and improves gut motility in A53T mice: contributions of pro-brain-derived neurotrophic factor (PRO-BDNF) and mature BDNF. J Biol Chem 291(39):20811\u201320821. \n                    https:\/\/doi.org\/10.1074\/jbc.M116.744029","journal-title":"J Biol Chem"},{"key":"584_CR183","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"112","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O\u2019Mara A, Yonkers R, Kordower JH (2018) Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis 112:106\u2013118. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2018.01.008","journal-title":"Neurobiol Dis"},{"key":"584_CR184","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ensci.2017.12.002","volume":"10","author":"K Yamashiro","year":"2018","unstructured":"Yamashiro K, Tanaka R, Shimo Y, Oyama G, Ogawa T, Umemura A, Hattori N (2018) Cerebral microbleeds and blood pressure abnormalities in Parkinson\u2019s disease. NeurologicalSci 10:5\u201311. \n                    https:\/\/doi.org\/10.1016\/j.ensci.2017.12.002","journal-title":"NeurologicalSci"},{"issue":"1","key":"584_CR185","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5001\/omj.2015.02","volume":"30","author":"F Salawu","year":"2015","unstructured":"Salawu F, Olokoba A (2015) Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson\u2019s disease. Oman Med J 30(1):3\u201310. \n                    https:\/\/doi.org\/10.5001\/omj.2015.02","journal-title":"Oman Med J"},{"issue":"5","key":"584_CR186","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00002826-199010000-00008","volume":"13","author":"WC Koller","year":"1990","unstructured":"Koller WC, Vetere-Overfield B, Williamson A, Busenbark K, Nash J, Parrish D (1990) Sexual dysfunction in Parkinson\u2019s disease. Clin Neuropharmacol 13(5):461\u2013463","journal-title":"Clin Neuropharmacol"},{"issue":"Pt B","key":"584_CR187","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.expneurol.2017.06.018","volume":"298","author":"CW Olanow","year":"2017","unstructured":"Olanow CW, Kieburtz K, Katz R (2017) Clinical approaches to the development of a neuroprotective therapy for PD. Exp Neurol 298(Pt B):246\u2013251. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.018","journal-title":"Exp Neurol"},{"issue":"4","key":"584_CR188","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K (2014) Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimer\u2019s Res Ther 6(4):37. \n                    https:\/\/doi.org\/10.1186\/alzrt269","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1\u20132","key":"584_CR189","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.etp.2011.05.008","volume":"65","author":"K Radad","year":"2013","unstructured":"Radad K, Hassanein K, Moldzio R, Rausch WD (2013) Vascular damage mediates neuronal and non-neuronal pathology following short and long-term rotenone administration in Sprague-Dawley rats. Exp Toxicol Pathol 65(1\u20132):41\u201347. \n                    https:\/\/doi.org\/10.1016\/j.etp.2011.05.008","journal-title":"Exp Toxicol Pathol"},{"issue":"12","key":"584_CR190","doi-asserted-by":"publisher","first-page":"R774","DOI":"10.1016\/S0960-9822(06)00402-7","volume":"7","author":"N Killeen","year":"1997","unstructured":"Killeen N (1997) T-cell regulation: Thy-1\u2013hiding in full view. Curr Biol 7(12):R774\u2013777","journal-title":"Curr Biol"},{"issue":"3","key":"584_CR191","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/acel.12312","volume":"14","author":"M Rodriguez","year":"2015","unstructured":"Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M (2015) Parkinson\u2019s disease as a result of aging. Aging Cell 14(3):293\u2013308. \n                    https:\/\/doi.org\/10.1111\/acel.12312","journal-title":"Aging Cell"},{"key":"584_CR192","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neulet.2017.10.047","volume":"662","author":"X Li","year":"2018","unstructured":"Li X, Yang W, Chen M, Liu C, Yu S (2018) Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys. Neurosci Lett 662:276\u2013282. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2017.10.047","journal-title":"Neurosci Lett"},{"issue":"1","key":"584_CR193","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","volume":"25","author":"Y Chu","year":"2007","unstructured":"Chu Y, Kordower JH (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson\u2019s disease? Neurobiol Dis 25(1):134\u2013149. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.08.021","journal-title":"Neurobiol Dis"},{"issue":"1","key":"584_CR194","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0306-3623(96)00522-8","volume":"29","author":"TA Miller","year":"1997","unstructured":"Miller TA (1997) Control of circulation in insects. Gen Pharmacol 29(1):23\u201338","journal-title":"Gen Pharmacol"},{"issue":"1","key":"584_CR195","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autneu.2010.03.002","volume":"165","author":"HM Young","year":"2011","unstructured":"Young HM, Cane KN, Anderson CR (2011) Development of the autonomic nervous system: a comparative view. Auton Neurosci 165(1):10\u201327. \n                    https:\/\/doi.org\/10.1016\/j.autneu.2010.03.002","journal-title":"Auton Neurosci"},{"key":"584_CR196","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/B978-0-12-802900-8.00020-8","volume-title":"Comparative Anatomy and Histology","author":"JM Snyder","year":"2018","unstructured":"Snyder JM, Hagan CE, Bolon B, Keene CD (2018) 20\u2014Nervous System. In: Treuting PM, Dintzis SM, Montine KS (eds) Comparative Anatomy and Histology, 2nd edn. Academic Press, San Diego, pp 403\u2013444. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-802900-8.00020-8","edition":"2"},{"key":"584_CR197","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-12-374245-2.00004-8","volume-title":"The Rat Nervous System","author":"JB Furness","year":"2015","unstructured":"Furness JB (2015) Chapter 4\u2014peripheral autonomic nervous system. In: Paxinos G (ed) The Rat Nervous System, 4th edn. Academic Press, London, pp 61\u201376","edition":"4"},{"issue":"1","key":"584_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ar.1091270102","volume":"127","author":"RF Becker","year":"1957","unstructured":"Becker RF, Grunt JA (1957) The cervical sympathetic ganglia. Anat Rec 127(1):1\u201314","journal-title":"Anat Rec"},{"issue":"2","key":"584_CR199","doi-asserted-by":"publisher","first-page":"119","DOI":"10.11276\/jsvc.35.119","volume":"35","author":"M Hassimoto","year":"2002","unstructured":"Hassimoto M, Harada T (2002) Practical method for correcting QT intervals in experimental animals: QT correction formulas for beagle dogs and rhesus monkeys. Adv Anim Cardiol 35(2):119\u2013123. \n                    https:\/\/doi.org\/10.11276\/jsvc.35.119","journal-title":"Adv Anim Cardiol"},{"issue":"3\u20134","key":"584_CR200","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF03033569","volume":"11","author":"AB Manning-Bog","year":"2007","unstructured":"Manning-Bog AB, Langston JW (2007) Model fusion, the next phase in developing animal models for Parkinson\u2019s disease. Neurotox Res 11(3\u20134):219\u2013240","journal-title":"Neurotox Res"},{"issue":"3","key":"584_CR201","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/jpd-140368","volume":"4","author":"K Muthukumaran","year":"2014","unstructured":"Muthukumaran K, Smith J, Jasra H, Sikorska M, Sandhu JK, Cohen J, Lopatin D, Pandey S (2014) Genetic susceptibility model of Parkinson\u2019s disease resulting from exposure of DJ-1 deficient mice to MPTP: evaluation of neuroprotection by Ubisol-Q10. J Parkinsons Dis 4(3):523\u2013530. \n                    https:\/\/doi.org\/10.3233\/jpd-140368","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"584_CR202","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/hmg\/ddu748","volume":"24","author":"Y Niu","year":"2015","unstructured":"Niu Y, Guo X, Chen Y, Wang CE, Gao J, Yang W, Kang Y, Si W, Wang H, Yang SH, Li S, Ji W, Li XJ (2015) Early Parkinson\u2019s disease symptoms in alpha-synuclein transgenic monkeys. Hum Mol Genet 24(8):2308\u20132317. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu748","journal-title":"Hum Mol Genet"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-00584-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-018-00584-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-00584-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:01:34Z","timestamp":1589648494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-018-00584-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":202,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s10286-018-00584-7","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"17 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}